Rxivist logo

Impact of age-specific immunity on the timing and burden of the next Zika virus outbreak

By Michel J. Counotte, Christian L. Althaus, Nicola Low, Julien Riou

Posted 07 Jun 2019
bioRxiv DOI: 10.1101/661223 (published DOI: 10.1371/journal.pntd.0007978)

The 2015–2017 epidemics of Zika virus (ZIKV) in the Americas caused widespread protective immunity. The timing and burden of the next Zika virus outbreak remains unclear. We used an agent-based model to simulate the dynamics of age-specific immunity to ZIKV, and predict the future age-specific risk using data from Managua, Nicaragua. We also investigated the potential impact of a ZIKV vaccine. Assuming lifelong immunity, the risk of a ZIKV outbreak will remain low until 2035 and rise above 50% in 2047. The imbalance in age-specific immunity implies that people in the 15–29 age range will be at highest risk of infection during the next ZIKV outbreak, increasing the expected number of congenital abnormalities. ZIKV vaccine development and licensure are urgent to attain the maximum benefit in reducing the population-level risk of infection and the risk of adverse congenital outcomes. This urgency increases if immunity is not lifelong.

Download data

  • Downloaded 530 times
  • Download rankings, all-time:
    • Site-wide: 28,894 out of 88,847
    • In epidemiology: 384 out of 1,556
  • Year to date:
    • Site-wide: 22,074 out of 88,847
  • Since beginning of last month:
    • Site-wide: 49,689 out of 88,847

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)